
Bionyme Laboratories Private Limited
About Bionyme Laboratories Private Limited
Data last updated:
Bionyme Laboratories Private Limited is a private limited company based in Chennai, Tamil Nadu, India, recognised as a startup by DPIIT. It operates in the healthcare services segment of the healthcare sector. It was incorporated on 26 June 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U85100TN2021PTC144340.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Leeba Balan (Managing Director) and Sriram Chandrasekaran.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No. 16 1st Floor Bharathi Street Radha Nagar Chrompet, Chennai, Tamil Nadu, India – 600044.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.05 Lakh. For the same year it recorded a net loss of ₹6.09 Lakh and EBITDA of -₹6.06 Lakh.
Bionyme Laboratories Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0136726).
Company details
Recognitions & Rankings of Bionyme Laboratories
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-TN-02-0136726
Contact details
Bionyme Laboratories Private Limited's registered office is in Chennai, Tamil Nadu.
- Registered AddressNo. 16 1st Floor Bharathi Street Radha Nagar Chrompet, Chennai, Tamil Nadu, India – 600044
- IndustryHealthcare, Human Health Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Bionyme Laboratories Private Limited
FY 2025 filings availableBionyme Laboratories Private Limited reported revenue of ₹1.05 Lakh for FY 2023.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹6.06 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹6.09 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Bionyme Laboratories Private Limited, buy the company report.
Board of directors of Bionyme Laboratories Private Limited
Bionyme Laboratories has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sriram Chandrasekaran | Director | 26 Jun 2021 | 5 Years 4 Months | Current |
| Leeba Balan | Managing Director | 26 Jun 2021 | 5 Years 4 Months | Current |
Legal cases
No court or tribunal cases involving Bionyme Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bionyme Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Bionyme Laboratories Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Bionyme Laboratories Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Leeba Balan was appointed as Managing Director on 26 Jun 2021.
Frequently asked questions
Bionyme Laboratories is an active private limited company based in Chennai, Tamil Nadu, India. The company works in human health activities, within the healthcare industry. It was incorporated on 26 June 2021 (5+ years old) and is registered under CIN U85100TN2021PTC144340.
Bionyme Laboratories has 2 current directors:
- Leeba Balan - Managing Director
- Sriram Chandrasekaran - Director
The latest financial statements of Bionyme Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Bionyme Laboratories is U85100TN2021PTC144340. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bionyme Laboratories was incorporated on 26 June 2021, making it 5+ years old. It is registered with the Registrar of Companies, Chennai.
Leeba Balan was appointed as Managing Director on 26 Jun 2021. Sriram Chandrasekaran was appointed as Director on 26 Jun 2021.
Yes, Bionyme Laboratories is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Bionyme Laboratories is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-02-0136726).
The registered office of Bionyme Laboratories is at No. 16 1st Floor Bharathi Street Radha Nagar Chrompet, Chennai, Tamil Nadu, India – 600044.
Bionyme Laboratories operates in the healthcare industry, in the human health activities segment.

